Kidney failure care for migrants: a European survey
- PMID: 40232649
- DOI: 10.1007/s40620-025-02290-w
Kidney failure care for migrants: a European survey
Abstract
Background: The management of migrants with kidney failure and no medical insurance raises complex medical, social, financial, and ethical issues. The survey aimed to investigate (i) current practices in managing these patients, and (ii) the perspective of European nephrologists on ethical dilemmas and optimal care.
Methods: The survey was piloted by the ISN Western Europe Regional Board, with members of the Young Nephrologists' Platform (YNP) of the European Renal Association (ERA), and disseminated to European nephrologists in the ISN and YNP networks. Responses were collected anonymously via SurveyMonkey.
Results: A total of 378 responses were collected from 29 European countries. Most (57%) managed fewer than 3 migrant patients with kidney failure per week, while 10% managed more than 11. Most respondents indicated that access to dialysis was unrestricted (59%), although only 25% said migrant patients were systematically eligible for kidney transplantation. Many nephrologists (38%) were unaware of the directives of governmental bodies or hospital protocols regarding migrant patients. The most common obstacles to patient management included language non concordance (64%), uncertainty about the future (56%), and lack of knowledge of medical history (49%). Two-thirds felt managing migrant patients was a moral duty, though 52% reported stress within the clinical caregiving team.
Conclusion: Despite strong commitment from European nephrologists, a fragmented legal framework, remaining barriers, and uneven case distribution hinder optimal care for migrant patients with kidney disease.
Keywords: End-stage kidney disease; Hemodialysis; Kidney transplantation; Migrant patients; Peritoneal dialysis.
© 2025. The Author(s) under exclusive licence to Italian Society of Nephrology.
Conflict of interest statement
Declarations. Conflict of interest: CR received lecture grants from Alexion, consulting fees from Vifor, and travel grants form Sanofi-aventis, outside the submitted work. AK received research grants from CSL Vifor and Otsuka, consultancy fees from Amgen, AstraZeneca, Boehringer Ingelheim, CSL Vifor, Delta4, GlaxoSmithKline, Novartis, Novo Nordisk, Otsuka, Roche, Sobi and Walden Biosciences, and speaking fees from CSL Vifor and Otsuka, all outside the submitted work. SM received support for meeting registration and travel from Amgen and Sanofi Genzyme outside the submitted work. LL received consulting fees from Alexion, AstraZeneca, Biogen, BMS, GSK, Kezar, Novartis, Otsuka, Pfizer, and Sanofi; has participated in speaker bureau for Alexion, GSK and Roche and is a scientific advisor for Carna Health. All outside the submitted work. M.J.S. received honoraria as a speaker and consulting fees from Novo Nordisk, Jansen, Mundipharma, AstraZeneca, Esteve, Fresenius, Eli Lilly, Boehringer-Ingelheim, Vifor, ICU, Pfizer, Bayer, Travere Therapeutics, GE Healthcare, GSK, MEDICE and Otsuka. She is also one of the former Editors-in-Chief of CKJ. Current editorial board of American Society of Nephrology (ASN)journals. All outside of the submitted work. Ethical approval: The survey was anonymous. Ethics approval was waived by the ethical committee of the Modena Academic Hospital, as the data were collected anonymously and processed in aggregate. Informed consent: Not applicable.
Similar articles
-
An update on the global disparities in kidney disease burden and care across world countries and regions.Lancet Glob Health. 2024 Mar;12(3):e382-e395. doi: 10.1016/S2214-109X(23)00570-3. Lancet Glob Health. 2024. PMID: 38365413 Review.
-
Gender differences in the context of interventions for improving health literacy in migrants: a qualitative evidence synthesis.Cochrane Database Syst Rev. 2024 Dec 12;12(12):CD013302. doi: 10.1002/14651858.CD013302.pub2. Cochrane Database Syst Rev. 2024. PMID: 39665382
-
The experiences of adults who are on dialysis and waiting for a renal transplant from a deceased donor: a systematic review.JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):169-211. doi: 10.11124/jbisrir-2015-1973. JBI Database System Rev Implement Rep. 2015. PMID: 26447040
-
Challenges in the provision of healthcare services for migrants: a systematic review through providers' lens.BMC Health Serv Res. 2015 Sep 17;15:390. doi: 10.1186/s12913-015-1065-z. BMC Health Serv Res. 2015. PMID: 26380969 Free PMC article.
-
Evaluating an intervention to promote access to mental healthcare for low language proficient migrants and refugees across Europe (MentalHealth4All): study protocol for a pretest-post-test cross-national survey study.BMJ Open. 2025 Jul 7;15(7):e095868. doi: 10.1136/bmjopen-2024-095868. BMJ Open. 2025. PMID: 40623874 Free PMC article.
References
-
- Cervantes L, Tuot D, Raghavan R, Linas S, Zoucha J, Sweeney L et al (2018) Association of emergency-only vs standard hemodialysis with mortality and health care use among undocumented immigrants with end-stage renal disease. JAMA Intern Med 178:188–195 - PubMed
-
- Cervantes L, Tong A, Camacho C, Collings A, Powe NR (2021) Patient-reported outcomes and experiences in the transition of undocumented patients from emergency to scheduled hemodialysis. Kidney Int 99:198–207 - PubMed
-
- Van Biesen W, Vanholder R, Ernandez T, Drewniak D, Luyckx V (2018) Caring for migrants and refugees with end-stage kidney disease in Europe. Am J Kidney Dis 71:701–709 - PubMed
-
- Van Biesen W, Vanholder R, Vanderhaegen B, Lameire N, Wanner C, Wiecek A et al (2011) Renal replacement therapy for refugees with end-stage kidney disease: an international survey of the nephrological community. Kidney Int Suppl 2016(6):35–41
MeSH terms
LinkOut - more resources
Full Text Sources